Cardiovascular gene therapy: current status and therapeutic potential.
about
Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signallingApplications of regenerative medicine in organ transplantationGene delivery technologies for cardiac applicationsIntra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels.Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteriesElectroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury.Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfationEndovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.Gene targeting in ischemic heart disease and failure: translational and clinical studies.Myocardial therapeutic angiogenesis: a review of the state of development and future obstaclesMyocardial repair: from salvage to tissue reconstruction.Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology.Cardiac Regeneration using Growth Factors: Advances and Challenges.Pharmacologic therapy for intermittent claudication.Adult stem cells: from new cell sources to changes in methodology.Therapeutic neovascularization for coronary disease: current state and future prospects.Restenosis and therapy.Cardiovascular surgery for realization of regenerative medicine.Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.Angiogenic gene therapy for refractory angina.Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosisAnchoring of self-assembled plasmid DNA/anti-DNA antibody/cationic lipid micelles on bisphosphonate-modified stent for cardiovascular gene delivery.The (PrS/HGF-pDNA) multilayer films for gene-eluting stent coating: Gene-protecting, anticoagulation, antibacterial properties, and in vivo antirestenosis evaluation.Utility of vascular endothelial specific peptides for enhancement of adeno-associated virus-mediated gene transfer.Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.Gene Therapy in Heart Failure.10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb.Anti-DNA antibody modified coronary stent for plasmid gene delivery: results obtained from a porcine coronary stent model.Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
P2860
Q24304298-E96DB432-28E4-4BA3-87EB-B085BC036227Q26801226-B275BDF9-6BEF-4F44-A465-4D9F8B68B731Q26863362-936D625C-0874-4A07-8BE0-F7D483B33A98Q33486302-99684EAB-B0E0-4347-AF77-DA81CC720CCCQ34943604-19AF3552-18E1-46CC-A81C-7766F99C1155Q34977697-E06DDAB1-7279-43EA-A3BD-B1F891DFB493Q34993431-E27E96E1-376D-4408-B79D-769895D9CD95Q35110751-E9977069-E450-4D9A-A9E3-E58B181110BDQ35802696-2F3A29D9-22BB-42EB-A3CD-0E7E1C103929Q35879491-345D612F-EE15-445F-8C1A-EEF3051E187CQ35893044-8568F4AF-8128-4E9B-9394-C38E45CFA7A1Q36401348-C77BA78F-5877-4336-AA43-A9EF8BF11D59Q36617570-08143D71-ED55-4B74-8993-8CF43DE3F298Q36820684-F92430C1-3161-4EE7-9E62-187FE7A79D65Q37176440-3601691C-2B76-4A3D-8593-597E4B2CC09CQ37304690-6465F4EF-4F97-401E-BA5E-CBBB8C287E3BQ37316330-1F12AD79-BF7F-4E18-BB17-4B5D41289D30Q37461418-D4769848-E79B-4AF9-A4A8-09465775930EQ37815089-E596CE81-29E7-410F-BB47-094BFBB09B53Q37895528-1A4E45AD-D1AC-4A24-92FC-71B8BE2DCCA8Q38001437-3E894209-810F-49F0-88D2-A8100A78225BQ38039022-90FC5A88-C3B5-4D3E-8221-C5890811D924Q38081027-1F86101D-2C5A-44DA-A59B-B56DABC63861Q38637597-B1C25E80-C986-456C-8704-1C9849FB9FAFQ38647828-7452966A-FB95-4DC3-9DB4-73CE92938B75Q39149753-2B3D3746-CC67-4B29-A3C6-BFAD31238790Q39178723-45866C26-507E-433C-B8E3-74FC55B003BCQ39527743-3D5495E7-7D41-4936-A6BF-2E08C24C326FQ41018640-4F920C12-FB6A-4738-814B-9B76D5E71C88Q42066164-095ECCBC-2204-497B-8F4B-468E37F48BA7Q45861410-F5131999-0B2D-4742-A1D6-854CAD5C861EQ45871974-795E8122-52EA-419C-B9B4-C5F8989355CEQ50528049-5A6D7960-8B06-480D-96FD-4CEFA51D57A6Q57342839-A9CCF925-A4B8-46FB-AC3E-9D8151A2B5BD
P2860
Cardiovascular gene therapy: current status and therapeutic potential.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular gene therapy: current status and therapeutic potential.
@ast
Cardiovascular gene therapy: current status and therapeutic potential.
@en
type
label
Cardiovascular gene therapy: current status and therapeutic potential.
@ast
Cardiovascular gene therapy: current status and therapeutic potential.
@en
prefLabel
Cardiovascular gene therapy: current status and therapeutic potential.
@ast
Cardiovascular gene therapy: current status and therapeutic potential.
@en
P2860
P356
P1476
Cardiovascular gene therapy: current status and therapeutic potential
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707315
P407
P577
2007-06-11T00:00:00Z